Introduction: Modern management of acute myeloid leukemia

Characteristics and outcome of patients with therapy-related acute promyelocytic leukemia front-line treated with or without arsenic trioxide.

Leukemia·2017

Expression of CD33 is a predictive factor for effect of gemtuzumab ozogamicin at different doses in adult acute myeloid leukaemia.

Leukemia·2016

A comparison of clofarabine with ara-C, each in combination with daunorubicin as induction treatment in older patients with acute myeloid leukaemia.

Leukemia·2016

Optimal induction and post-remission therapy for acute myeloid leukemia.

Leukemia supplements·2016

The HSP90 inhibitor ganetespib: A potential effective agent for Acute Myeloid Leukemia in combination with cytarabine.

Leukemia research·2015

A randomised comparison of the novel nucleoside analogue sapacitabine with low-dose cytarabine in older patients with acute myeloid leukaemia.

Leukemia·2015

Closing the disease modification gap: Emerging therapies in myelofibrosis beyond JAK inhibition.

Seminars in hematology·2026

The current state of cerebral complications of sickle cell disease.

Seminars in hematology·2026

Blood or marrow transplantation and cellular therapies in myeloproliferative neoplasms: A comprehensive review.

Seminars in hematology·2026

The thrombopoietin receptor in myeloproliferative neoplasms: A unifying mechanism of disease pathogenesis and therapeutic targeting.

Seminars in hematology·2026

Management of myeloproliferative neoplasms in pregnancy: Essential thrombocythemia, polycythemia vera, and primary myelofibrosis.

Seminars in hematology·2026

Germline predisposition in myeloproliferative neoplasms.

Seminars in hematology·2026

Targeted drug delivery of rosuvastatin via nanoemulgel: A step towards more effective rheumatoid arthritis therapy.

International immunopharmacology·2026

Recent advances in hidradenitis suppurativa therapeutics: a focus on existing and future medical therapeutics.

Expert opinion on emerging drugs·2026

Spatiotemporal Nanotherapy After Myocardial Infarction: Targeting the Inflammatory-to-reparative Transition With Extracellular Vesicles and Engineered Nanoparticles.

Cardiovascular drugs and therapy·2026

Gold-graphene based nanofiber biosensor for selective electrochemical identification of CD105-positive canine mesenchymal stem cells.

Mikrochimica acta·2026

Local Nanomedicine and Nano-Enabled Biomaterials After Glioblastoma Resection.

International journal of nanomedicine·2026

Retraction: Quantitative GABA magnetic resonance spectroscopy as a measure of motor learning function in the motor cortex after subarachnoid hemorrhage.

Frontiers in neurology·2026

Related Experiment Videos

Introduction: Modern management of acute myeloid leukemia

Related Concept Videos

Characteristics and outcome of patients with therapy-related acute promyelocytic leukemia front-line treated with or without arsenic trioxide.

Expression of CD33 is a predictive factor for effect of gemtuzumab ozogamicin at different doses in adult acute myeloid leukaemia.

A comparison of clofarabine with ara-C, each in combination with daunorubicin as induction treatment in older patients with acute myeloid leukaemia.

Optimal induction and post-remission therapy for acute myeloid leukemia.

The HSP90 inhibitor ganetespib: A potential effective agent for Acute Myeloid Leukemia in combination with cytarabine.

A randomised comparison of the novel nucleoside analogue sapacitabine with low-dose cytarabine in older patients with acute myeloid leukaemia.

Closing the disease modification gap: Emerging therapies in myelofibrosis beyond JAK inhibition.

The current state of cerebral complications of sickle cell disease.

Blood or marrow transplantation and cellular therapies in myeloproliferative neoplasms: A comprehensive review.

The thrombopoietin receptor in myeloproliferative neoplasms: A unifying mechanism of disease pathogenesis and therapeutic targeting.

Management of myeloproliferative neoplasms in pregnancy: Essential thrombocythemia, polycythemia vera, and primary myelofibrosis.

Germline predisposition in myeloproliferative neoplasms.

Targeted drug delivery of rosuvastatin via nanoemulgel: A step towards more effective rheumatoid arthritis therapy.

Recent advances in hidradenitis suppurativa therapeutics: a focus on existing and future medical therapeutics.

Spatiotemporal Nanotherapy After Myocardial Infarction: Targeting the Inflammatory-to-reparative Transition With Extracellular Vesicles and Engineered Nanoparticles.

Gold-graphene based nanofiber biosensor for selective electrochemical identification of CD105-positive canine mesenchymal stem cells.

Local Nanomedicine and Nano-Enabled Biomaterials After Glioblastoma Resection.

Retraction: Quantitative GABA magnetic resonance spectroscopy as a measure of motor learning function in the motor cortex after subarachnoid hemorrhage.

Related Experiment Videos

Introduction: Modern management of acute myeloid leukemia

Related Concept Videos

Related Articles